TMLL yields 200.00% · PFE yields 6.13%● Live data
📍 TMLL pulled ahead of the other in Year 1
Combined, TMLL + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TMLL + PFE for your $10,000?
Tele Group Corp., a development stage Web 2.0 software company, develops Internet properties and applications primarily in the United States. The company offers a range of search, display, and interactive advertising products to reach and engage targeted consumers. Its products under development consist of NeXplore Search, a search engine, featuring a graphical user interface to allow the user to interact with the search results themselves and the advertisements that are presented to them, as well as to refine their search results by leveraging the collective intelligence of social communities of other users; and NeXplore Ads, a proprietary ad creation and management platform that enables marketers to create, manage, and modify, in real time, targeted interactive online advertising campaigns. The company's developing products also include HitLabel.com, a Web destination to offer music contests, and to provide musicians with viral tools for promoting their work and staying in tune with their fans; MyCircle.com, a universally accessible, application-agnostic social computing platform to offer users with a single, customizable interface for managing various facets of their online activity; and AdCircle, an interactive, graphical, and online classified advertising platform for buyers and sellers. The company was formerly known as NeXplore Corporation and changed its name to Tele Group Corp. in December 2020. Tele Group Corp was incorporated in 2007 and is headquartered in New York, New York.
Full TMLL Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.